From Seekingalpha · SA Transcripts · · 40s
EyePoint Shares DURAVYU Trial Results
EyePoint reveals DURAVYU's Phase III results for wet age-related macular degeneration.
In brief
EyePoint reveals DURAVYU's Phase III results for wet age-related macular degeneration. EyePoint Inc. reported DURAVYU's Phase III top-line results for wet age-related macular degeneration. Originally reported by Seekingalpha.
EyePoint Inc. (EYPT)
EyePoint Inc. published a slide deck discussing DURAVYU's Phase III top-line results for wet age-related macular degeneration.
DURAVYU Trial Results
DURAVYU's Phase III top-line results for wet age-related macular degeneration were discussed by EyePoint Inc. in a slide deck.
Slide Deck Published
EyePoint Inc. released a slide deck for this event with 162.54K followers on SA Transcripts.
In short
EyePoint Inc. reported DURAVYU's Phase III top-line results for wet age-related macular degeneration.
